KR102202554B1 - Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product - Google Patents

Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product Download PDF

Info

Publication number
KR102202554B1
KR102202554B1 KR1020190088973A KR20190088973A KR102202554B1 KR 102202554 B1 KR102202554 B1 KR 102202554B1 KR 1020190088973 A KR1020190088973 A KR 1020190088973A KR 20190088973 A KR20190088973 A KR 20190088973A KR 102202554 B1 KR102202554 B1 KR 102202554B1
Authority
KR
South Korea
Prior art keywords
extract
weight
cosmetic composition
fermented product
grape seed
Prior art date
Application number
KR1020190088973A
Other languages
Korean (ko)
Inventor
설현정
이소헌
이강혁
장준환
이상국
박헌주
Original Assignee
주식회사 현대바이오랜드
서울대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 현대바이오랜드, 서울대학교산학협력단 filed Critical 주식회사 현대바이오랜드
Priority to KR1020190088973A priority Critical patent/KR102202554B1/en
Application granted granted Critical
Publication of KR102202554B1 publication Critical patent/KR102202554B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine

Abstract

The present invention relates to a cosmetic composition made of a natural material-derived material. More specifically, the present invention provides a cosmetic composition which contains a complex of a Saururus chinensis leaf extract, a grape seed extract, a Portulaca oleracea extract, and a hard-boiled rice fermented product, thereby having no side effects and excellent skin whitening effects. The mixture is mixed with 2 to 3 parts by weight of grape seeds, and 6 to 7 parts by weight of Portulaca oleracea with respect to 1 part by weight of Saururus chinensis leaves.

Description

삼백초잎 추출물, 포도씨 추출물, 마치현 추출물 및 고두밥 발효물을 포함하는 피부 미백용 화장료 조성물 {Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product} Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product}

본 발명은 삼백초잎 추출물, 포도씨 추출물, 마치현 추출물 및 고두밥 발효물을 포함하는 피부 미백용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for skin whitening comprising the extract of Sambaekcho leaf, the extract of grape seed, the extract of machi-suki and the fermented godubap.

화장품 분야에서 동아시아 여성들 특히 한국, 일본, 중국의 여성들에게 가장 관심이 큰 분야중 하나는 피부 미백이다. 피부 미백과 관련하여 가장 중요한 요소는 피부 멜라닌 색소이다. 멜라닌(melanin)은 동물, 식물, 미생물 등에서 발견되는 검은 색소로 생육이나 발달에 필수적이지 않지만 특정 환경에 대한 생존력과 경쟁력을 높여주는 물질이다. 동물에서의 멜라닌은 피부병과 악성 멜라노마(melanoma)와 관계가 있으며, 티로시나제(tyrosinase)에 의해 타이로신(tyrosine)으로부터 생산되는 도파 멜라닌(DOPA melanin) 외에 DHN 멜라닌, GDHB 멜라닌, 카테콜 멜라닌(catechol melanin) 등이 보고되어 있다[Bell, A. A. and Weeler M. H., Ann. Rev. Phytophathol. 24, 411, 1986].In the cosmetic field, one of the areas of interest to East Asian women, especially Korean, Japanese, and Chinese women, is skin whitening. The most important factor in skin whitening is the skin melanin pigment. Melanin (melanin) is a black pigment found in animals, plants, microorganisms, etc., and is not essential for growth or development, but is a substance that enhances viability and competitiveness for a specific environment. Melanin in animals is related to skin disease and malignant melanoma, and in addition to DOPA melanin produced from tyrosine by tyrosinase, DHN melanin, GDHB melanin, catechol melanin ) Have been reported [ Bell, AA and Weeler MH, Ann. Rev. Phytophathol. 24, 411, 1986 ].

멜라닌이 과잉생산되면 이를 피부 밖으로 계속적으로 내보내면서 국소 부위에서 기미가 생성되거나, 피부가 검어지게 된다. 따라서 피부에 멜라닌이 과도하게 침착되는 것을 방지하고, 피부 내 색소함량을 줄이기 위한 다양한 미백방법이 주목 받고 있다. 주요 방법으로는 자외선 차단, 멜라닌 색소를 신속하게 표백(bleaching) 시키는 방법, 생합성 된 멜라닌이 멜라노좀에 실려 각질형성세포로 전단되는 단계를 차단하는 방법, 멜라닌 생합성의 속도결정 단계인 티로시나제 활성을 억제하는 방법, 멜라닌형성세포의 세포막으로부터 티로시나제 활성 및 생합성 촉징을 유도하는 신호전달을 차단하는 방법, 멜라닌 생성 세포에 특이적으로 독성을 나타내는 물질을 투여하는 방법 등이 있다[Son KH, Heo MY. Int J Cosmeti Sci. 35: 9-18. 2013].When melanin is overproduced, it is continuously released out of the skin, and spots are generated in local areas, or the skin becomes black. Therefore, various whitening methods to prevent excessive deposition of melanin on the skin and to reduce the pigment content in the skin are attracting attention. The main methods are UV protection, rapid bleaching of melanin pigments, blocking the step of biosynthetic melanin being loaded onto melanosomes and shearing into keratinocytes, inhibiting tyrosinase activity, which is the step of determining the rate of melanin biosynthesis. Method, a method of blocking signal transduction that induces tyrosinase activity and biosynthesis from the cell membrane of melanocytes, and a method of administering a substance that is specifically toxic to melanogenic cells [ Son KH, Heo MY. Int J Cosmeti Sci. 35: 9-18. 2013 ].

현재까지 멜라닌 합성의 중요한 인자로 알려져 있는 티로시나제를 억제하는 대포적인 물질로는 알부틴(arbutin), 코직산(kojic acid), 하이드로퀴논(hydroquinone), 비타민 C(vitamin C) 등이 있으며, 특히 알부틴은 티로시나아제 활성 억제 기능과 더불어 5,6-dihydroxyindole-2-carboxylic acid(DHICA) polymerase 활성으로 인한 멜라노좀 생성 억제 효과도 가지고 있다고 알려져 있다. 하지만 이들 물질들의 안정성 및 안전성에 대한 문제점, 그리고 부작용에 대한 논란은 계속되고 있다. Arbutin, kojic acid, hydroquinone, vitamin C, etc., as cannonball substances that inhibit tyrosinase, which is known as an important factor in melanin synthesis, are known to date. It is known that it has an inhibitory effect on the production of melanosomes due to 5,6-dihydroxyindole-2-carboxylic acid (DHICA) polymerase activity in addition to the synase activity inhibition function. However, controversy about the stability and safety of these substances and side effects continues.

따라서, 기존에 알려진 멜라닌 생성을 억제하는 소재들이 가지고 있는 문제점들을 극복하고 보다 안전하고 우수한 효과를 갖는 소재를 탐색하기 위하여 천연물 유래 소재들에 대한 연구가 대두되고 있는 실정이다. Therefore, research on materials derived from natural substances is on the rise in order to overcome the problems of existing known materials that suppress melanin production and search for a material having a safer and superior effect.

대한민국 공개특허 제10-2018-0048408호(2018.05.10.공개)에는 쉰다리 전통 발효 기술에 의해 피부 미백 효능이 증진된 삼백초를 함유하는 피부 미백용 화장료 조성물 및 그 제조방법이 개시되어 있다.Republic of Korea Patent Publication No. 10-2018-0048408 (published on May 10, 2018) discloses a cosmetic composition for skin whitening and a method for manufacturing the same, which contains three baekchos having improved skin whitening effect by using a traditional fermentation technique. 대한민국 등록특허 제10-1744579호(2017.06.01.등록)에는 수련, 캐모마일꽃, 모링가 및 마치현의 혼합 추출물을 함유하는 피부 미백용 화장료 조성물이 개시되어 있다.Republic of Korea Patent Registration No. 10-1744579 (registered on January 1, 2017) discloses a cosmetic composition for skin whitening containing a mixed extract of water lily, chamomile flower, moringa, and machi.

본 발명은 천연물 유래의 소재를 활용하여, 피부미백능이 우수한 화장료 조성물을 개발하여 제공하는 것을 목적으로 한다.An object of the present invention is to develop and provide a cosmetic composition having excellent skin whitening ability by utilizing a material derived from a natural product.

본 발명은 삼백초(Saururus chinensis) 잎, 포도씨(Grape seed), 마치현(Portulaca oleracea) 혼합물의 혼합 추출물 및 고두밥(rice)에 누룩을 접종하여 발효시킨 발효물을 포함하는 것을 특징으로 하는 피부 미백용 화장료 조성물을 제공한다.The present invention is a cosmetic for skin whitening comprising a mixed extract of a mixture of Saururus chinensis leaves, Grape seed, and Portulaca oleracea , and a fermented product obtained by inoculating yeast into rice and fermenting it. The composition is provided.

본 발명에 있어서, 상기 혼합물은, 바람직하게 삼백초 잎 1 중량부에 대하여, 포도씨 2 내지 3 중량부, 마치현 6 내지 7 중량부로 혼합되는 것이 좋다.In the present invention, the mixture is preferably mixed in an amount of 2 to 3 parts by weight of grape seeds and 6 to 7 parts by weight of machihyun, based on 1 part by weight of the leaves of Sambaekcho.

본 발명에 있어서, 상기 혼합 추출물과 발효물은, 바람직하게 건조 중량 기준으로 혼합 추출물 70~95 중량부에 발효물 5~30 중량부로 혼합되는 것이 좋다.In the present invention, the mixed extract and the fermented product are preferably mixed in an amount of 5 to 30 parts by weight of the fermented product to 70 to 95 parts by weight of the mixed extract on a dry weight basis.

또한, 본 발명은 삼백초(Saururus chinensis) 잎 추출물, 포도씨(Grape seed) 추출물, 마치현(Portulaca oleracea) 추출물 및 고두밥(rice)에 누룩을 접종하여 발효시킨 발효물을 포함하는 것을 특징으로 하는 피부 미백용 화장료 조성물을 제공한다.In addition, the present invention for skin whitening, characterized in that it comprises a fermented product fermented by inoculating yeast into a sambaekcho ( Saururus chinensis ) leaf extract, grape seed (Grape seed) extract, portulaca oleracea extract, and godubap (rice) It provides a cosmetic composition.

본 발명에 있어서, 상기 삼백초 잎 추출물, 포도씨 추출물, 마치현 추출물은, 바람직하게 건조 중량 기준으로 삼백초잎 추출물 1 중량부에 대하여, 포도씨 추출물 2 내지 3 중량부, 마치현 추출물 6 내지 7 중량부로 피부 미백용 화장료 조성물에 혼합되는 것이 좋다.In the present invention, the Sambaekcho leaf extract, grape seed extract, and portulaca oleracea extract are preferably used for skin whitening in 2 to 3 parts by weight of grape seed extract, and 6 to 7 parts by weight of portulaca oleracea extract based on 1 part by weight of the Sambaekcho leaf extract based on dry weight. It is better to be mixed with the cosmetic composition.

본 발명에 있어서, 상기 삼백초 잎 추출물, 포도씨 추출물, 마치현 추출물 및 발효물은, 바람직하게 상기 삼백초 잎 추출물, 포도씨 추출물, 마치현 추출물을 합친 것 70~95 중량부에 발효물 5~30 중량부의 비율로 혼합되는 것이 좋다.In the present invention, the Sambaekcho leaf extract, grape seed extract, portulaca oleracea extract, and fermented product are preferably 70 to 95 parts by weight of the sum of the Sambaekcho leaf extract, grape seed extract, and portulaca oleracea extract in a ratio of 5 to 30 parts by weight of the fermented product. Good to be mixed.

한편, 본 발명의 미백용 화장료 조성물에 있어서, 상기 추출물은, 바람직하게 추출용매로 에탄올 수용액을 사용하여 추출한 것이 좋다.Meanwhile, in the cosmetic composition for whitening of the present invention, the extract is preferably extracted using an aqueous ethanol solution as an extraction solvent.

한편, 본 발명의 미백용 화장료 조성물에 있어서, 상기 발효물은, 바람직하게 발효 후, 여과를 거쳐 수득한 여과액인 것이 좋다.Meanwhile, in the cosmetic composition for whitening of the present invention, the fermented product is preferably a filtrate obtained through filtration after fermentation.

삼백초잎 및 포도씨의 경우 우수한 미백 효능을 보이는 소재임에도 불구하고, 세포 독성으로 말미암아 그 사용이 제한적인 문제점이 있었다. 하지만, 본 발명에서는 이들 성분에 마치현 추출물 및 고두밥 발효물을 첨가함으로써 세포독성이 줄어듦을 확인할 수 있었고, 이를 통해 부작용이 없으면서도 미백 효과를 나타내는 본 발명의 삼백초잎, 포도씨, 마치현 추출물 및 고두밥 발효물을 복합물로 함유하는 화장료 조성물로 개발할 수 있었다.In the case of Sambaekcho leaves and grape seeds, although they are materials showing excellent whitening efficacy, there is a problem that their use is limited due to cytotoxicity. However, in the present invention, it was confirmed that the cytotoxicity was reduced by adding the fermented machisuki extract and the fermented godubap to these ingredients.Through this, it was confirmed that the whitening effect without side effects was observed. It was possible to develop a cosmetic composition containing as a composite.

도 1은 삼백초 잎 및 포도씨의 멜라노마 세포(B16-F1)를 이용한 독성테스트 결과 그래프이다.
도 2는 제조예 1 내지 9의 멜라노마 세포(B16-F1)를 이용한 독성테스트 결과 그래프이다.
도 3은 제조예 10 내지 15의 멜라노마 세포(B16-F1)를 이용한 독성테스트 결과 그래프이다.
도 4는 멜라노마 세포(B16-F1)를 이용한 멜라닌 생합성 억제 효과 실험 결과 그래프이다.
도 5는 멜라노제네시스 관련 Tyrosinase, TRP-1, TRP-2 mRNA 발현량 조사 실험 결과 그래프이다.
도 6은 멜라노좀 수송 관련 Rab27a, MyosinVa, Melanophilin mRNA 발현량 조사 실험 결과 그래프이다.
1 is a graph showing the results of a toxicity test using melanoma cells (B16-F1) of three baekcho leaves and grape seeds.
Figure 2 is a graph of the results of the toxicity test using melanoma cells (B16-F1) of Preparation Examples 1 to 9.
3 is a graph of the results of a toxicity test using melanoma cells (B16-F1) of Preparation Examples 10 to 15.
4 is a graph showing the results of an experiment on the inhibitory effect of melanin biosynthesis using melanoma cells (B16-F1).
5 is a graph showing the results of an experiment for measuring the expression levels of Tyrosinase, TRP-1, and TRP-2 mRNA related to melanogenesis.
6 is a graph showing the results of an experiment for measuring the expression levels of Rab27a, MyosinVa, and Melanophilin mRNA related to melanosome transport.

본 발명은 삼백초(Saururus chinensis) 잎, 포도씨(Grape seed), 마치현(Portulaca oleracea) 혼합물의 혼합 추출물 및 고두밥(rice)에 누룩을 접종하여 발효시킨 발효물을 포함하는 것을 특징으로 하는 피부 미백용 화장료 조성물을 제공한다. The present invention is a cosmetic for skin whitening comprising a mixed extract of a mixture of Saururus chinensis leaves, Grape seed, and Portulaca oleracea , and a fermented product obtained by inoculating yeast into rice and fermenting it. The composition is provided.

또한, 삼백초(Saururus chinensis) 잎 추출물, 포도씨(Grape seed) 추출물, 마치현(Portulaca oleracea) 추출물 및 고두밥(rice)에 누룩을 접종하여 발효시킨 발효물을 포함하는 것을 특징으로 하는 피부 미백용 화장료 조성물을 제공한다. In addition, a cosmetic composition for skin whitening, characterized in that it comprises a fermented product obtained by inoculating yeast on rice and inoculating sauerkraut ( Saururus chinensis ) leaf extract, grape seed extract, portulaca oleracea extract, and fermentation. to provide.

삼백초(Saururus chinensis)는 제주도와 지리산 일부 지역에서 나는 다년생 초본으로, 습기가 많은 계곡의 바람이 잘 통하고 공중습도가 높으며 반그늘인 곳에서 자란다. 한방 문헌에 따르면 삼백초는 각종 성인병 치료에 효능이 있다고 기록되어 있다. 삼백초는 탄닌 등이 피를 맑게 하고 모세혈관을 강화시키며 피의 흐름을 원활하게 해주어 노화방지에 우수한 효과가 있다고 알려져 있다. Saururus chinensis is a perennial herb that grows in some areas of Jeju Island and Jirisan Mountain, and grows in a humid valley where the air is well ventilated, the air humidity is high, and the shade is half shade. According to the herbal literature, it is recorded that Sambaekcho is effective in treating various adult diseases. Sambaekcho is known to have an excellent effect in anti-aging because tannins, etc., purify blood, strengthen capillaries, and smooth blood flow.

포도씨(Grape seed)는 폴리페놀이 많아 항산화 효능이 우수하다. 대표적으로 프로안토시아닌은 심혈관계질환 예방 효과, 노인성치매예방 효과, 항당뇨 효과, 대장암 예방 효과 등이 있으며, 강력한 항산화 작용으로 면역력을 높일 수 있다. 또한 레스베라트롤은 포도가 곰팡이로부터 자신을 보호하기 위해 생성하는 물질로, 강력한 항산화작용을 하여 세포의 손상과 노화를 막는 역할을 한다. 레스베라트롤은 포도의 알갱이, 포도 껍질, 포도씨 순으로 많이 함유되어 있으며, 혈중 콜레스테롤 저하에 도움을 주기도 한다.Grape seeds are high in polyphenols and have excellent antioxidant efficacy. Representatively, proanthocyanin has the effect of preventing cardiovascular disease, preventing senile dementia, anti-diabetic effect, and preventing colon cancer, and can increase immunity with strong antioxidant activity. In addition, resveratrol is a substance produced by grapes to protect itself from fungi, and it acts as a powerful antioxidant to prevent cell damage and aging. Resveratrol is contained in the order of grains of grapes, grape skins, and grape seeds, and it helps lower blood cholesterol.

마치현(Portulaca oleracea)은 쇠비름, 장명채, 과자엽채, 오행초라고도 한다. 전국 각지에 야생하며, 전세계에 분포한다. 뿌리는 흰색이고 줄기는 붉은빛이 도는 갈색으로 많은 가지가 비스듬히 옆으로 퍼져 자란다. 마치현은 해열, 해독, 지혈효과가 있으며 항균효과도 보고된바 있다. Portulaca oleracea is also known as purslane, Jangmyeongchae, confectionery, and five elements. It is wild all over the country and is distributed all over the world. The roots are white, and the stems are reddish brown, with many branches spreading to the side and growing. Machihyeon has antipyretic, detoxifying, and hemostatic effects, and antibacterial effects have also been reported.

쌀(rice)은 벼과에 속하는 식물인 벼의 열매 껍질을 벗긴 알맹이이다. 고두밥은 아주 되게 지어 고들고들하게 지은 된밥을 말하며, 쌀을 잘 씻어 하룻밤 정도 충분히 불리고, 1~2시간 정도 물기를 빼고 찜통이나 시루에서 증기로 쪄 내어 제조한다. 본 발명에서는 이와 같이 제조한 고두밥에 누룩을 접종하여 발효시킨 발효물을 사용한다.Rice is a peeled kernel of rice, a plant belonging to the rice family. Godubap refers to the rice that has been cooked very well and carefully cooked, and it is prepared by washing the rice well and soaking it overnight, draining it for 1 to 2 hours, and steaming it in a steamer or a steamer. In the present invention, a fermented product obtained by inoculating yeast and fermenting the prepared godubap is used.

본 발명은 상기와 같은 효능이 있는 생약재를 이용하여, 피부 미백용 화장료 조성물을 개발하고자 하였는데, 하기 본 발명의 실험에 의할 경우, 삼백초잎 추출물, 포도씨 추출물, 마치현 추출물 및 고두밥 누룩 발효물의 복합물을 포함하는 본 발명의 조성물은 우수한 피부 미백 효능을 나태는 것으로 것으로 확인되었다. The present invention was to develop a cosmetic composition for skin whitening by using the herbal medicines having the above efficacy, but according to the experiment of the present invention, a complex of Sambaekcho leaf extract, grape seed extract, portulaca oleracea extract and fermented Godubap yeast It was confirmed that the composition of the present invention including the present invention exhibits excellent skin whitening effect.

본 발명에서는 삼백초잎, 포도씨, 마치현을 혼합한 후, 여기에 추출용매를 첨가한 후, 추출하여 사용할 수 있다. 다만, 또 다른 실시예로, 삼백초잎, 포도씨, 마치현 각각에 추출용매를 첨가하여 각각 추출한 삼백초잎 추출물, 포도씨 추출물, 마치현 추출물을 혼합하여 사용할 수도 있다. 추출시 추출용매로는 정제수, 메탄올, 에탄올, 글리세린, 에틸아세테이트, 부틸렌글리콜, 프로필렌글리콜, 디클로로메탄, 헥산 용매를 각각 단독 또는 이들을 2종 이상 혼합한 혼합용매를 이용할 수 있다. 다만, 바람직하게는 에탄올 수용액을 사용하여 추출한 것을 사용하는 것이 좋은데, 더욱 바람직하게는 50% 에탄올 수용액을 사용하는 것이 좋다. 추출 용매 외에 기타 추출 방법은 당업계에 널리 알려진 방법을 사용할 수 있다.In the present invention, after mixing three baekcho leaves, grape seeds and machihyeon, the extraction solvent is added thereto, and then extracted and used. However, as another embodiment, it is also possible to mix and use the extract of the extract of the extract of the extract of the extract of the leaf of the cedarium, the extract of the extract of the seed of the grape, and the extract of the extract of the machi-hyeon, respectively extracted by adding an extraction solvent to each of the three baekcho leaves, grape seeds, and machihyeon. During extraction, as an extraction solvent, purified water, methanol, ethanol, glycerin, ethyl acetate, butylene glycol, propylene glycol, dichloromethane, and hexane solvents may be used alone or a mixed solvent in which two or more solvents thereof are mixed may be used. However, preferably, it is good to use the one extracted by using an aqueous ethanol solution, more preferably a 50% aqueous ethanol solution. In addition to the extraction solvent, other extraction methods may use methods well known in the art.

본 발명의 화장료 조성물에 있어서, 발효물은 고두밥(rice)에 누룩을 접종하여 발효시킨 발효물을 의미하는데, 바람직하게는 여과하여 걸리진 여과액을 사용하는 것이 좋다. 고두밥은 쌀알을 불린 후 증기처리하여 제조할 수 있으며, 고두밥과 누룩을 혼합하여 고두밥 발효물을 제조할 수 있다. 이 때, 여과는 당업계에 널리 알려진 통상적인 방법을 사용할 수 있다.In the cosmetic composition of the present invention, the fermented product refers to a fermented product obtained by inoculating yeast on rice and fermenting it, and preferably, a filtrate obtained by filtering is used. Godubap can be prepared by steaming after soaking rice grains, and a fermented godubap can be prepared by mixing godubap and yeast. In this case, filtration may be performed using a conventional method well known in the art.

한편, 본 발명의 삼백초(Saururus chinensis) 잎, 포도씨(Grape seed), 마치현(Portulaca oleracea) 혼합물의 혼합 추출물 및 고두밥(rice)에 누룩을 접종하여 발효시킨 발효물을 포함하는 것을 특징으로 하는 피부 미백용 화장료 조성물에 있어서, 상기 삼백초 잎 추출물, 포도씨 추출물, 마치현은 바람직하게 삼백초잎 1 중량부에 대하여, 포도씨 2 내지 3 중량부, 마치현 6 내지 7 중량부로 혼합되는 것이 좋다. 또한, 상기 혼합 추출물과 발효물은 바람직하게 건조 중량 기준으로, 혼합 추출물 70~95 중량부에 발효물 5~30 중량부로 혼합되는 것이 좋다. 또한, 상기 혼합 추출물과 발효물을 포함하는 복합물은 건조 중량 기준으로 화장료 조성물 전체 중량에 대하여 1 내지 20 중량%로 함유하는 것이 좋다.On the other hand, skin whitening, characterized in that it comprises a fermented product fermented by inoculating yeast into rice and a mixed extract of a mixture of Saururus chinensis leaves, grape seed, and portulaca oleracea of the present invention. In the cosmetic composition for, the three baekcho leaf extract, grape seed extract, and machihyeon are preferably mixed with 2 to 3 parts by weight of grape seeds and 6 to 7 parts by weight of machihyun based on 1 part by weight of the three baekcho leaves. In addition, the mixed extract and the fermented product are preferably mixed in an amount of 5 to 30 parts by weight of the fermented product in 70 to 95 parts by weight of the mixed extract on a dry weight basis. In addition, it is preferable to contain the composite including the mixed extract and the fermented product in an amount of 1 to 20% by weight based on the total weight of the cosmetic composition.

한편, 본 발명의 또 다른 실시예인 삼백초(Saururus chinensis) 잎 추출물, 포도씨(Grape seed) 추출물, 마치현(Portulaca oleracea) 추출물 및 고두밥(rice)에 누룩을 접종하여 발효시킨 발효물을 포함하는 것을 특징으로 하는 피부 미백용 화장료 조성물에 있어서, 상기 삼백초 잎 추출물, 포도씨 추출물, 마치현 추출물은, 바람직하게 건조 중량 기준으로 삼백초 잎 추출물 1 중량부에 대하여, 포도씨 추출물 2 내지 3 중량부, 마치현 추출물 6 내지 7 중량부로 피부 미백용 화장료 조성물에 혼합되는 것이 좋다. 또한, 상기 삼백초 잎 추출물, 포도씨 추출물, 마치현 추출물 및 발효물은 삼백초 잎 추출물, 포도씨 추출물, 마치현 추출물을 합친 것 70~95 중량부에 발효물 5~30 중량부의 비율로 혼합되는 것이 좋다. 또한, 상기 혼합 추출물과 발효물을 포함하는 복합물은 건조 중량 기준으로 화장료 조성물 전체 중량에 대하여 1 내지 20 중량%로 함유하는 것이 좋다.On the other hand, it is characterized in that it comprises a fermented product fermented by inoculating yeast into another embodiment of the present invention, Saururus chinensis leaf extract, grape seed extract, portulaca oleracea extract, and godubap (rice). In the cosmetic composition for skin whitening, the Sambaekcho leaf extract, grape seed extract, and portulaca oleracea extract are, preferably, based on dry weight, based on 1 part by weight of the Sambaekcho leaf extract, 2 to 3 parts by weight of grape seed extract, 6 to 7 parts by weight of machihyun extract It is better to be mixed with the cosmetic composition for skin whitening. In addition, the Sambaekcho leaf extract, grape seed extract, portulaca oleracea extract, and fermented product are preferably mixed in a ratio of 5 to 30 parts by weight of the fermented product to 70 to 95 parts by weight of a combination of the Sambaekcho leaf extract, grape seed extract, and portulaca oleracea extract. In addition, it is preferable to contain the composite including the mixed extract and the fermented product in an amount of 1 to 20% by weight based on the total weight of the cosmetic composition.

한편, 본 발명의 화장료 조성물은, 일 예로, 용액, 현탁액, 유탁액, 페이스트, 화장수, 젤, 수용성 리퀴드, 크림, 에센스, 계면활성제-함유 클렌징, 오일, 수중유(O/W)형 및 유중수(W/O)형 중 선택되는 어느 하나의 기초 화장료 제형; 스킨; 로션; 아이크림; 수딩젤; 연고; 마스크팩용 제형; 바디워시용 제형; 필링젤; 수중유형 및 유중수형 메이크업베이스; 파운데이션; 스킨커버; 립스틱, 립그로스, 페이스파우더, 투웨이케익, 아이새도, 치크칼라 및 아이브로우 펜슬류 중 선택되는 어느 하나의 색조화장료 제형; 두피용 제형; 중에서 선택되는 어느 하나인 것일 수 있다.On the other hand, the cosmetic composition of the present invention, for example, solution, suspension, emulsion, paste, lotion, gel, water-soluble liquid, cream, essence, surfactant-containing cleansing, oil, oil in water (O/W) type and oil Any one basic cosmetic formulation selected from heavy water (W/O) type; skin; Lotion; Eye cream; Soothing gel; Ointment; Formulation for mask pack; Formulation for body wash; Peeling gel; Water-in-water and water-in-oil makeup base; foundation; Skin cover; Any one color cosmetic formulation selected from lipstick, lip gloss, face powder, two-way cake, eye sado, cheek color, and eyebrow pencil; Formulation for scalp; It may be any one selected from among.

또한, 본 발명의 화장료 조성물은 화장 분야에서 통상적으로 사용되는 보조제 예컨대 친수성 또는 친유성 활성제, 보존제, 항산화제, 용매, 방향제, 충전제, 차단제, 안료, 흡취제, 염료 등을 함유할 수 있다. 이들 다양한 보조제의 양은 당해 분야에서 통상적으로 사용되는 양이며, 예컨대 조성물 총 중량에 대해 0.001 내지 30 중량% 이다. 다만, 어떠한 경우라도 보조제 및 그 비율은 본 발명에 따른 화장료 조성물의 바람직한 성질에 악영향을 미치지 않도록 선택될 것이다.In addition, the cosmetic composition of the present invention may contain auxiliary agents commonly used in the cosmetic field, such as hydrophilic or lipophilic activators, preservatives, antioxidants, solvents, fragrances, fillers, blockers, pigments, odorants, dyes, and the like. The amounts of these various adjuvants are those commonly used in the art, such as 0.001 to 30% by weight based on the total weight of the composition. However, in any case, the adjuvant and its ratio will be selected so as not to adversely affect the desirable properties of the cosmetic composition according to the present invention.

한편, 본 발명의 화장료 조성물에 있어서, 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌글리콜, 실리콘, 벤토나이트, 실라카, 탈크 또는 산화아연 등이 이용될 수 있다.On the other hand, in the cosmetic composition of the present invention, when the formulation is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, tragacanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silaka as carrier components , Talc or zinc oxide may be used.

또한, 본 발명의 화장료 조성물에 있어서, 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 일례로 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤조에이트, 프로필렌글리콜, 1,3-부틸렌글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌글리콜 또는 소리비탄의 지방산 에스테르가 이용될 수 있다.In addition, in the cosmetic composition of the present invention, when the formulation is a solution or emulsion, a solvent, a solubilizing agent or an emulsifying agent is used as a carrier component, for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, Benzoate, propylene glycol, 1,3-butylene glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of soribitan may be used.

또한 본 발명의 화장료 조성물에 있어서, 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소 결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라가칸트 등이 이용될 수 있다.In addition, in the cosmetic composition of the present invention, when the formulation is a suspension, a liquid diluent such as water, ethanol or propylene glycol, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, and polyoxyethylene sorbitan ester as carrier components. The same suspending agent, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tragacanth, and the like may be used.

한편, 본 발명의 화장료 조성물에 있어서, 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.On the other hand, in the cosmetic composition of the present invention, when the formulation is a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, or polyamide powder may be used as a carrier component. In particular, in the case of a spray, additionally Propellants such as chlorofluorohydrocarbon, propane/butane or dimethyl ether.

한편, 본 발명의 화장료 조성물에 있어서, 제형이 계면활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.On the other hand, in the cosmetic composition of the present invention, when the formulation is a surfactant-containing cleansing, as a carrier component, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, sarcosinate, Fatty acid amide ether sulfates, alkylamidobetaines, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters may be used.

또한, 본 발명의 화장료 조성물에 있어서, 계면활성제 함유 클렌징 제형 또는 계면활성제 비함유 클렌징 제형 또는 비누일 경우에는, 피부에 도포한 후 닦아내거나 떼거나 물로 씻어낼 수도 있다. 일례로, 상기 비누는 액상비누, 가루비누, 고형비누 및 오일비누이며, 상기 계면활성제 함유 클렌징 제형은 클렌징 폼, 클렌징 워터, 클렌징 수건 및 클렌징 팩이며, 상기 계면활성제 비함유 클렌징 제형은 클렌징크림, 클렌징 로션, 클렌징 워터 및 클렌징 젤이며, 이에 한정되는 것은 아니다.In addition, in the cosmetic composition of the present invention, in the case of a surfactant-containing cleansing formulation or a surfactant-free cleansing formulation or soap, it may be applied to the skin and then wiped off, removed, or washed with water. As an example, the soap is liquid soap, powder soap, solid soap and oil soap, the surfactant-containing cleansing formulation is a cleansing foam, cleansing water, cleansing towel and cleansing pack, and the surfactant-free cleansing formulation is a cleansing cream, Cleansing lotion, cleansing water, and cleansing gel, but are not limited thereto.

또한, 본 발명의 화장료 조성물은 본 발명 이외의 다른 화장료 조성물과 중복하여 사용할 수 있다. 또한 본 발명에 따른 화장료 조성물은 통상적인 사용방법에 따라 사용될 수 있으며, 사용자의 피부 상태 또는 취향에 따라 그 사용횟수를 달리할 수 있다.In addition, the cosmetic composition of the present invention can be used in conjunction with other cosmetic compositions other than the present invention. In addition, the cosmetic composition according to the present invention may be used according to a conventional method of use, and the number of times of use thereof may be changed according to a user's skin condition or taste.

이하, 본 발명에 대해 하기 제조예, 실시예 및 실험예에서 더욱 상세히 설명하고자 한다. 다만, 본 발명의 권리범위가 하기 제조예, 실시예 및 실험예에만 한정되는 것은 아니고, 이와 등가의 기술적 사상의 변형까지를 모두 포함한다.Hereinafter, the present invention will be described in more detail in the following Preparation Examples, Examples and Experimental Examples. However, the scope of the present invention is not limited to the following manufacturing examples, examples, and experimental examples, and includes all modifications of the equivalent technical idea.

[실험예 1 : 멜라노마 세포(B16-F1)를 이용한 세포 독성 평가][Experimental Example 1: Evaluation of cytotoxicity using melanoma cells (B16-F1)]

삼백초잎 및 포도씨의 독성을 측정하기 위해서 상업적으로 구입한 마우스의 멜라노마(B16-F1) 세포에 시료를 처리하여 실험을 실시하였다. 6 well plate에 10% 소혈청이 함유된 DMEM(Dulbecco's modified Eagle's medium) 배지와 멜라노마(B16-F1) 세포를 1×105세포/well 농도로 분주하고 24시간 동안 37℃ 5% CO2 조건에서 배양하였다. 이때, 실험에 사용할 시료는 삼백초잎 및 포도씨 각각에 50%(v/v) 에탄올을 원료의 6배 가량 첨가하여 상온에서 3일간 추출한 후, 추출물을 0.45㎛로 여과한 뒤 감압 농축한 것을 사용하였다. In order to measure the toxicity of three baekcho leaves and grape seeds, an experiment was performed by treating a sample in melanoma (B16-F1) cells of a commercially purchased mouse. DMEM (Dulbecco's modified Eagle's medium) medium containing 10% bovine serum and melanoma (B16-F1) cells were dispensed at a concentration of 1×10 5 cells/well in a 6 well plate, and 37 5% CO 2 condition for 24 hours Cultured in. At this time, the sample to be used in the experiment was extracted by adding about 6 times the amount of 50% (v/v) ethanol to each of Sambaekcho leaves and grape seeds for 3 days at room temperature, and the extract was filtered with 0.45㎛ and concentrated under reduced pressure. .

24시간 후 시료(삼백초잎 50% 에탄올 추출물 및 포도씨의 50% 에탄올 추출물)를 α-Melanocyte stimulate hormone(α-MSH)과 10% 소혈청이 포함된 새로운 DMEM 배지에 농도 별로 희석하여 72시간 동안 배양한다. 72시간 배양 후 배지 모두 제거하고, 2.5mg/㎖의 MTT 가용액을 10배 희석시킨 배지로 교체하여 4시간 배양기에서 배양한다. 4시간 후 상등액을 제거하고, 2㎖ DMSO(dimethhyl sulfoxide) 용액을 첨가하여 생성된 MTT formazan 결정체를 570nm에서 흡광을 측정하였다. After 24 hours, the samples (50% ethanol extract of Sambaekcho leaves and 50% ethanol extract of grape seeds) were diluted by concentration in a new DMEM medium containing α-Melanocyte stimulate hormone (α-MSH) and 10% bovine serum and cultured for 72 hours. do. After 72 hours of incubation, all of the medium was removed, and 2.5 mg/ml of MTT soluble solution was replaced with a 10-fold diluted medium, and cultured in a 4 hour incubator. After 4 hours, the supernatant was removed, and MTT formazan crystals produced by adding 2 ml dimethhyl sulfoxide (DMSO) solution were measured for absorbance at 570 nm.

대조군(Control)은 용해 용매로 사용된 DMSO(dimethhyl sulfoxide)를 처리한 것을 사용하였으며, α-MSH 처리군은 α-MSH와 용해 용매로 사용된 DMSO(dimethhyl sulfoxide)를 함께 처리한 것을 사용하였다. 양성대조군으로는 Arbutin(SK Bioland)을 사용하였다. 독성 테스트 결과는 아래 표 1과 도 1에 나타내었다.The control group was treated with DMSO (dimethhyl sulfoxide) used as a dissolving solvent, and the α-MSH treated group was treated with α-MSH and dimethhyl sulfoxide (DMSO) used as a dissolving solvent. Arbutin (SK Bioland) was used as a positive control. The toxicity test results are shown in Table 1 and FIG. 1 below.

SampleSample Conc.(㎍/㎖)Conc.(㎍/㎖) Cell viability (%)Cell viability (%) ControlControl 97.2197.21 α-MSH 처리군α-MSH treatment group 100.00100.00 α-MSH +
삼백초잎 추출물
α-MSH +
Sambaekcho Leaf Extract
0.10.1 96.5296.52
0.250.25 93.8393.83 0.50.5 74.1274.12 1One 67.6267.62 2.52.5 58.5358.53 55 52.8352.83 1010 48.9948.99 α-MSH +
포도씨 추출물
α-MSH +
Grape seed extract
1One 91.5591.55
1010 85.3985.39 2525 77.7677.76 5050 57.5457.54 100100 44.8244.82 250250 40.1240.12 α-MSH + Arbutinα-MSH + Arbutin 100100 88.1788.17

상기 실험에 따라 멜라노마에서의 세포독성을 확인한 바, 삼백초잎 추출물은 0.5 ㎍/㎖, 포도씨 추출물은 25 ㎍/㎖ 농도에서부터 세포 독성을 보였다.According to the above experiment, cytotoxicity in melanoma was confirmed. The extract of Sambaekcho leaf showed cytotoxicity from 0.5 µg/ml and 25 µg/ml of grape seed extract.

[실험예 2: 세포독성 완화를 위한 혼합 추출물의 제조][Experimental Example 2: Preparation of mixed extract for alleviating cytotoxicity]

본 실험예에서는 삼백초 잎과 포도씨의 세포 독성을 완화하기 위한 물질로 마치현을 선별하여 삼백초 및 포도씨의 세포 독성을 완화하고자 하였다. 삼백초 잎, 포도씨, 마치현을 하기 표 2의 배합비(중량비)로 총 100g 혼합한 후, 50%(v/v) 에탄올 600g을 넣고 상온에서 3일간 추출한 후 0.45㎛로 여과하고, 여과액을 감압 농축한 후 진공 건조한 파우더를 제조하였다.In this experimental example, it was attempted to alleviate the cytotoxicity of Sambaekcho and grape seeds by selecting the machi-hyun as a substance for alleviating the cytotoxicity of leaves and grape seeds. After mixing a total of 100g of leaves, grape seeds, and machisuki at the mixing ratio (weight ratio) shown in Table 2 below, 600g of 50% (v/v) ethanol was added, extracted for 3 days at room temperature, filtered to 0.45㎛, and the filtrate was concentrated under reduced pressure. Then, vacuum-dried powder was prepared.

삼백초잎Sambaekcho Leaf 포도씨Grape seed 마치현Machi Prefecture 제조예 1Manufacturing Example 1 55 33 22 제조예 2Manufacturing Example 2 33 22 1One 제조예 3Manufacturing Example 3 22 1One 1One 제조예 4Manufacturing Example 4 1One 22 22 제조예 5Manufacturing Example 5 1One 22 1One 제조예 6Manufacturing Example 6 1One 44 55 제조예 7Manufacturing Example 7 1One 33 66 제조예 8Manufacturing Example 8 1One 22 77 제조예 9Manufacturing Example 9 1One 1One 1One

획득한 파우더의 독성을 측정하기 위하여 상업적으로 구입한 마우스의 멜라노마(B16-F1) 세포에 시료를 처리하여 실험을 실시하였다. 6 well plate에 10% 소혈청이 함유된 DMEM(Dulbecco’s modified Eagle’s medium) 배지와 멜라노마(B16-F1) 세포를 1×105세포/well 농도로 분주하고 24시간 동안 37℃, 5% CO2 조건에서 배양하였다.In order to measure the toxicity of the obtained powder, an experiment was performed by treating a sample in melanoma (B16-F1) cells of a commercially purchased mouse. DMEM (Dulbecco's modified Eagle's medium) medium containing 10% bovine serum and melanoma (B16-F1) cells were dispensed at a concentration of 1×10 5 cells/well in a 6 well plate, and 37℃, 5% CO 2 for 24 hours. Incubated under conditions.

24시간 후 시료를 α-Melanocyte stimulate hormone(α-MSH)과 10% 소혈청이 포함된 새로운 DMEM 배지에 농도 별로 희석하여 72시간 동안 배양한다. 72시간 배양 후 배지 모두 제거하고, 2.5mg/㎖의 MTT 가용액을 10배 희석시킨 배지로 교체하여 4시간 배양기에서 배양한다. 4시간 후 상등액을 제거하고, 2㎖ DMSO(dimethhyl sulfoxide) 용액을 첨가하여 생성된 MTT formazan 결정체를 570nm에서 흡광을 측정하였다.After 24 hours, the sample is diluted by concentration in a new DMEM medium containing α-Melanocyte stimulate hormone (α-MSH) and 10% bovine serum and incubated for 72 hours. After 72 hours of incubation, all of the medium is removed, and 2.5 mg/mL of MTT soluble solution is replaced with a 10-fold diluted medium and cultured in an incubator for 4 hours. After 4 hours, the supernatant was removed, and MTT formazan crystals produced by adding 2 ml dimethhyl sulfoxide (DMSO) solution were measured for absorbance at 570 nm.

대조군(Control)은 용해 용매로 사용된 DMSO(dimethhyl sulfoxide)를 처리한 것을 사용하였으며, α-MSH 처리군은 α-MSH와 용해 용매로 사용된 DMSO(dimethhyl sulfoxide)를 함께 처리한 것을 사용하였다. 양성대조군으로는 Arbutin(SK Bioland)을 사용하였다. 독성 테스트 결과는 아래 표 3 및 도 2에 나타내었다.The control group was treated with DMSO (dimethhyl sulfoxide) used as a dissolving solvent, and the α-MSH treated group was treated with α-MSH and dimethhyl sulfoxide (DMSO) used as a dissolving solvent. Arbutin (SK Bioland) was used as a positive control. The toxicity test results are shown in Table 3 and FIG. 2 below.

SampleSample Conc.(㎍/㎖)Conc.(㎍/㎖) Cell viability (%)Cell viability (%) ControlControl 98.1798.17 α-MSH 처리군α-MSH treatment group 100.00100.00 제조예 1Manufacturing Example 1 5050 46.7646.76 100100 38.9338.93 제조예 2Manufacturing Example 2 5050 44.744.7 100100 34.7934.79 제조예 3Manufacturing Example 3 5050 45.2745.27 100100 35.4635.46 제조예 4Manufacturing Example 4 5050 67.6267.62 100100 55.0255.02 제조예 5Manufacturing Example 5 5050 63.5163.51 100100 52.4152.41 제조예 6Manufacturing Example 6 5050 82.6982.69 100100 78.1578.15 제조예 7Manufacturing Example 7 5050 85.1285.12 100100 83.4883.48 제조예 8Manufacturing Example 8 5050 97.2197.21 100100 96.8496.84 제조예 9Manufacturing Example 9 5050 56.1156.11 100100 47.5247.52 α-MSH + Arbutinα-MSH + Arbutin 100100 88.1488.14

실험 결과, 마치현 혼합 추출물의 첨가에 의해 세포 독성이 완화된 것으로 나타났고, 특히 제조예 7 및 제조예 8에서 세포 독성 완효 효과가 가장 우수하게 나타났다. As a result of the experiment, it was found that the cytotoxicity was alleviated by the addition of the mixed extract of Macho vulgaris, and in particular, in Preparation Examples 7 and 8, the cytotoxic mitigation effect was most excellent.

[실험예 3: 삼백초 잎, 포도씨, 마치현 추출물 및 고두밥 발효 여과물의 복합물 제조] [Experimental Example 3: Preparation of a complex product of three baekcho leaves, grape seeds, portulaca oleracea extract and fermented godubap filtrate]

본 실험예에서는 상기에서 제조한 삼백초 잎, 포도씨, 마치현 혼합 추출물 중 세포 독성 평가 결과가 우수했던 제조예 7 및 8에 고두밥 발효 여과물을 첨가하여 독성 완화 효과를 확인하고자 하였다.In this experimental example, it was attempted to confirm the toxicity mitigation effect by adding the fermented filtrate of godubap to Preparation Examples 7 and 8, which had excellent cytotoxicity evaluation results among the mixed extracts of Sambaekcho leaves, grape seeds, and machisalis prepared above.

잘 불린 쌀알에 3배수 정제수를 넣고 3시간 불린 후 150℃ 스팀으로 30분간 처리하여 고두밥을 제조하였다. 고두밥을 식힌 후, 고두밥과 누룩((주)송학곡자, 소율곡)을 1:1비율로 혼합한 후 1시간 이상 방치하였다. 이후 혼합물 중량의 3배수에 해당하는 정제수를 넣고 40℃에서 1일간 숙성한 뒤 90℃로 승온한 후 1시간 가온 및 멸균한다. 제조과정 종료 후 0.45μm로 여과한 액을 감압농축하여 고두밥 발효 여과물을 제조하였다. 상기 제조예 7 및 제조예 8의 혼합 추출물 파우더와 고두밥 발효 여과물 파우더를 아래 표 4와 같이 배합하였다. Three times purified water was added to well-soaked rice grains, soaked for 3 hours, and then treated with 150°C steam for 30 minutes to prepare godubap. After cooling the godubap, godubap and nuruk (Songhakgokja Co., Ltd., Soyulgok) were mixed at a ratio of 1:1 and left for at least 1 hour. After that, purified water equivalent to 3 times the weight of the mixture is added, aged at 40°C for 1 day, heated to 90°C, and heated and sterilized for 1 hour. After the completion of the manufacturing process, the filtered solution was concentrated under reduced pressure with 0.45 μm to prepare a fermented godubap filtrate. The mixed extract powder of Preparation Example 7 and Preparation Example 8 and the fermented filtrate powder of Godubap were blended as shown in Table 4 below.

구분division 제조예 7Manufacturing Example 7 고두밥 발효 여과물Godubap fermentation filtrate 제조예 10Manufacturing Example 10 9595 55 제조예 11Manufacturing Example 11 9090 1010 제조예 12Manufacturing Example 12 7070 3030 구분division 제조예 8Manufacturing Example 8 고두밥 발효 여과물Godubap fermentation filtrate 제조예 13Manufacturing Example 13 9595 55 제조예 14Manufacturing Example 14 9090 1010 제조예 15Manufacturing Example 15 7070 3030

상기 제조예 10 내지 15의 세포독성을 측정하기 위해서 상업적으로 구입한 마우스의 멜라노마(B16-F1) 세포에 시료를 처리하여 실험을 실시하였다. 6 well plate에 10% 소혈청이 함유된 DMEM(Dulbecco’s modified Eagle’s medium) 배지와 멜라노마(B16-F1) 세포를 1×105세포/well 농도로 분주하고 24시간 동안 37℃, 5% CO2 조건에서 배양하였다.In order to measure the cytotoxicity of Preparation Examples 10 to 15, an experiment was performed by treating a sample with melanoma (B16-F1) cells of a commercially purchased mouse. DMEM (Dulbecco's modified Eagle's medium) medium containing 10% bovine serum and melanoma (B16-F1) cells were dispensed at a concentration of 1×10 5 cells/well in a 6 well plate, and 37℃, 5% CO 2 for 24 hours. Incubated under conditions.

24시간 후 시료를 α-Melanocyte stimulate hormone(α-MSH)과 10% 소혈청이 포함된 새로운 DMEM 배지에 농도 별로 희석하여 72시간 동안 배양한다. 72시간 배양 후 배지 모두 제거하고, 2.5mg/㎖의 MTT 가용액을 10배 희석시킨 배지로 교체하여 4시간 배양기에서 배양한다. 4시간 후 상등액을 제거하고, 2㎖ DMSO(dimethhyl sulfoxide) 용액을 첨가하여 생성된 MTT formazan 결정체를 570nm에서 흡광을 측정하였다.After 24 hours, the sample is diluted by concentration in a new DMEM medium containing α-Melanocyte stimulate hormone (α-MSH) and 10% bovine serum and incubated for 72 hours. After 72 hours of incubation, all of the medium was removed, and 2.5 mg/ml of MTT soluble solution was replaced with a 10-fold diluted medium, and cultured in a 4 hour incubator. After 4 hours, the supernatant was removed, and MTT formazan crystals produced by adding 2 ml dimethhyl sulfoxide (DMSO) solution were measured for absorbance at 570 nm.

대조군(Control)은 용해 용매로 사용된 DMSO(dimethhyl sulfoxide)를 처리한 것을 사용하였으며, α-MSH 처리군은 α-MSH와 용해 용매로 사용된 DMSO(dimethhyl sulfoxide)를 함께 처리한 것을 사용하였다. 양성대조군으로는 Arbutin(SK Bioland)을 사용하였다. 독성 테스트 결과는 아래 표 5 및 도 3에 나타내었다.The control group was treated with DMSO (dimethhyl sulfoxide) used as a dissolving solvent, and the α-MSH treated group was treated with α-MSH and dimethhyl sulfoxide (DMSO) used as a dissolving solvent. Arbutin (SK Bioland) was used as a positive control. The toxicity test results are shown in Table 5 and FIG. 3 below.

SampleSample Conc.(㎍/㎖)Conc.(㎍/㎖) Cell viability (%)Cell viability (%) ControlControl 98.4798.47 α-MSH 처리군α-MSH treatment group 100.00100.00 제조예 10Manufacturing Example 10 5050 98.7898.78 100100 97.7797.77 제조예 11Manufacturing Example 11 5050 90.1190.11 100100 89.1789.17 제조예 12Manufacturing Example 12 5050 89.1289.12 100100 87.0287.02 제조예 13Manufacturing Example 13 5050 99.7899.78 100100 98.6298.62 제조예 14Manufacturing Example 14 5050 90.1890.18 100100 89.9489.94 제조예 15Manufacturing Example 15 5050 91.3191.31 100100 89.6489.64 α-MSH + Arbutinα-MSH + Arbutin 100100 89.4189.41

도 3에서 보듯이, 삼백초 잎, 포도씨, 마치현 혼합 추출물에 고두밥 발효 여과물을 첨가할 경우 세포 독성이 완화되는 것을 확인하였다. 특히, 제조예 10 및 제조예 13에서 세포 독성이 가장 우수하게 완화된 것으로 나타났다. As shown in FIG. 3, it was confirmed that the cytotoxicity was alleviated when the fermented godubap filtrate was added to the mixed extract of Sambaekcho leaves, grape seeds, and machihyeon. In particular, it was found that the cytotoxicity was most excellently alleviated in Preparation Example 10 and Preparation Example 13.

[실험예 4 : 멜라노마(B16-F1) 세포를 이용한 멜라닌 생합성 억제 효과 측정][Experimental Example 4: Measurement of melanin biosynthesis inhibitory effect using melanoma (B16-F1) cells]

본 실험에서는 상기 실시예에서 세포 독성이 가장 우수하게 완화된 것으로 확인된 제조예 10 및 제조예 13의 미백효능을 측정하고자 하였다.In this experiment, it was intended to measure the whitening efficacy of Preparation Examples 10 and 13, which were found to have the best alleviation of cytotoxicity in the above Examples.

상업적으로 구입한 마우스의 멜라노마(B16-F1) 세포에 시료를 처리하여 실험을 실시하였다. 6 well plate에 10% 소혈청이 함유된 DMEM(Dulbecco’s modified Eagle’s medium) 배지와 멜라노마(B16-F1) 세포를 1×105세포/well 농도로 분주하고 24시간 동안 37℃, 5% CO2 조건에서 배양하였다.The experiment was carried out by treating the sample with melanoma (B16-F1) cells of commercially purchased mice. DMEM (Dulbecco's modified Eagle's medium) medium containing 10% bovine serum and melanoma (B16-F1) cells were dispensed at a concentration of 1×10 5 cells/well in a 6 well plate, and 37℃, 5% CO 2 for 24 hours. Incubated under conditions.

24시간 후 시료를 α-Melanocyte stimulate hormone(α-MSH)과 10% 소혈청이 포함된 새로운 DMEM 배지에 농도 별로 희석하여 72시간 동안 배양한다. 72시간 배양 후 배지 모두 제거한 세포를 PBS(phosphate buffer, saline) 2㎖로 세척하고 1N NaOH 0.5㎖을 처리하여 세포를 1.5㎖ tube로 수거하여 세포 내 멜라닌을 얻었다. 수거한 세포를 96 well plate에 옮긴 후 450nm에서 흡광도를 측정하여 일정 단백질당 멜라닌양을 구하였다.After 24 hours, the sample is diluted by concentration in a new DMEM medium containing α-Melanocyte stimulate hormone (α-MSH) and 10% bovine serum and incubated for 72 hours. After 72 hours of incubation, cells from which all of the medium was removed were washed with 2 ml of PBS (phosphate buffer, saline) and treated with 0.5 ml of 1N NaOH to collect the cells into a 1.5 ml tube to obtain intracellular melanin. The collected cells were transferred to a 96 well plate, and the absorbance was measured at 450 nm to determine the amount of melanin per protein.

양성 대조군으로는 Arbutin(SK Bioland)을 사용하였다. 멜라닌 생합성 저해 테스트 결과는 아래 표 6 및 도 4에 나타내었다.Arbutin (SK Bioland) was used as a positive control. The melanin biosynthesis inhibition test results are shown in Table 6 and FIG. 4 below.

SampleSample Conc.(㎍/㎖)Conc.(㎍/㎖) Melanin formation per cell (%)Melanin formation per cell (%) ControlControl 33.9133.91 α-MSH 처리군α-MSH treatment group 100.00100.00 α-MSH + 제조예 10α-MSH + Preparation Example 10 55 85.4685.46 1010 82.8582.85 2525 80.7480.74 5050 79.8979.89 100100 75.3175.31 α-MSH + 제조예 13α-MSH + Preparation Example 13 55 83.3183.31 1010 80.9680.96 2525 77.0577.05 5050 66.8166.81 100100 56.5656.56 α-MSH + Arbutinα-MSH + Arbutin 100100 52.1052.10

상기 표 6 및 도 3에서 보듯이, 본 발명의 제조예 10 및 제조예 13 복합물은 단위 세포당 멜라닌 생성을 농도 의존적으로 억제함을 알 수 있었다.As shown in Table 6 and FIG. 3, it was found that the composites of Preparation Example 10 and Preparation 13 of the present invention inhibited melanin production per unit cell in a concentration-dependent manner.

[실험예 5 : 멜라노제네시스 관련 tyrosinase, TRP-1, TRP-2 mRNA 발현량 조사][Experimental Example 5: Investigation of the expression level of tyrosinase, TRP-1, TRP-2 mRNA related to melanogenesis]

본 실험에서는 상기 실험예 4에서 멜라닌 생성 억제 효과가 우수했던 제조예 13 복합물의 멜라노제네시스 관련 미백 효과를 측정하고자 하였다.In this experiment, the melanogenesis-related whitening effect of the composite of Preparation Example 13, which had excellent melanin production inhibitory effect in Experimental Example 4, was measured.

상업적으로 구입한 마우스의 멜라노마(B16-F1) 세포에 시료를 처리하여 실험을 실시하였다. 6 well plate에 10% 소혈청이 함유된 DMEM(Dulbecco’s modified Eagle’s medium) 배지와 멜라노마(B16-F1) 세포를 2×105세포/well 농도로 분주하고 24시간 동안 37℃, 5% CO2 조건에서 배양하였다.The experiment was carried out by treating the sample with melanoma (B16-F1) cells of commercially purchased mice. DMEM (Dulbecco's modified Eagle's medium) medium containing 10% bovine serum and melanoma (B16-F1) cells were dispensed at a concentration of 2×10 5 cells/well in a 6 well plate, and 37℃, 5% CO 2 for 24 hours. Incubated under conditions.

24시간 후 시료를 α-Melanocyte stimulate hormone(α-MSH)과 10% 소혈청이 포함된 새로운 DMEM 배지에 농도 별로 희석하여 24시간 동안 배양하였다. 24시간 배양 후 배지 모두 제거한 세포를 PBS(phosphate buffer, saline) 2㎖로 세척하고 세포를 TRIzol(invitrogen, USA)로 모아 RNA를 분리하였다. 분리된 RNA를 Qubit fluoremeter with RNA BR Assay kit 를 이용하여 정량한 뒤 cDNA (complementary DNA)를 합성하여 Real-time PCR을 실시하였다. cDNA합성은 cDNA 합성 Kit (High Capacity RNA to-cDNA Kit, Applied Biosystems, USA)를 사용하였고 Kit의 방법에 따라 실험을 수행하였다. Real-Time PCR: 7500 Fast with Power SYBR Green PCR master mix (Applied Biosystems, USA)을 이용하여 유전자를 증폭한 후 증폭산물을 정량 분석하였다. PCR에 사용된 Tyrosinase, TRP-1 및 TRP-2와 GAPDH primer는 코스모진텍사 (Korea)에서 합성하여 사용하였으며 primer sequence는 아래 표 7에 나타내었다.After 24 hours, the samples were diluted by concentration in a new DMEM medium containing α-Melanocyte stimulate hormone (α-MSH) and 10% bovine serum, and cultured for 24 hours. After culturing for 24 hours, the cells from which all the medium was removed were washed with 2 ml of PBS (phosphate buffer, saline), and the cells were collected with TRIzol (invitrogen, USA) to isolate RNA. The isolated RNA was quantified using a Qubit fluoremeter with RNA BR Assay kit, and then cDNA (complementary DNA) was synthesized to perform real-time PCR. For cDNA synthesis, a cDNA synthesis Kit (High Capacity RNA to-cDNA Kit, Applied Biosystems, USA) was used, and an experiment was performed according to the method of the Kit. Real-Time PCR: After amplifying the gene using 7500 Fast with Power SYBR Green PCR master mix (Applied Biosystems, USA), the amplified product was quantitatively analyzed. Tyrosinase, TRP-1, TRP-2, and GAPDH primers used in PCR were synthesized and used by Cosmo Genetec (Korea), and the primer sequences are shown in Table 7 below.

PrimerPrimer SenseSense AntisenseAntisense TyrosinaseTyrosinase 5'TATAAACTCAGTGTTTCCCTTTATCACAA-3'5'TATAAACTCAGTGTTTCCCTTTATCACAA-3' 5'-TCTATGATGACATGAAGTGGCAAA-3'5'-TCTATGATGACATGAAGTGGCAAA-3' TRP-1TRP-1 5'-GTTCAATGGCCAGGTCAGGA-3'5'-GTTCAATGGCCAGGTCAGGA-3' 5'-CAACGCAGCCACTACAGCA-3'5'-CAACGCAGCCACTACAGCA-3' TRP-2TRP-2 5'-TGG CTC ACT CCT TCC TGA ATG-3'5'-TGG CTC ACT CCT TCC TGA ATG-3' 5'-CAA ACA CAG GGT CGT TGG CT-3'5'-CAA ACA CAG GGT CGT TGG CT-3' GAPDHGAPDH 5'-GGCATCTTGGGCTACACTGAG-3'5'-GGCATCTTGGGCTACACTGAG-3' 5'-GGAAGAGTGGGAGTTGCTGTTG-3'5'-GGAAGAGTGGGAGTTGCTGTTG-3'

대조군(Control)은 용해 용매로 사용된 DMSO(dimethhyl sulfoxide)를 처리한 것을 사용하였으며, α-MSH 처리군은 용해 용매로 사용된 DMSO(dimethhyl sulfoxide)를 함께 처리한 것을 사용하였다. 양성 대조군으로는 Arbutin(SK Bioland)을 사용하였다. 실험결과는 아래 표 8 및 도 5에 나타내었다.The control group was treated with DMSO (dimethhyl sulfoxide) used as a dissolving solvent, and the α-MSH treatment group was treated with DMSO (dimethhyl sulfoxide) used as a dissolving solvent. Arbutin (SK Bioland) was used as a positive control. The experimental results are shown in Table 8 and FIG. 5 below.

Sample NameSample Name Conc. (㎍/㎖)Conc. (㎍/mL) Tyrosinase
expression rate(%)
Tyrosinase
expression rate(%)
Stdev.Stdev. TRP-1 expression rate(%)TRP-1 expression rate(%) Stdev.Stdev. TRP-2 expression rate(%)TRP-2 expression rate(%) Stdev.Stdev.
ControlControl 64.3464.34 0.520.52 64.3464.34 4.454.45 81.7481.74 0.820.82 α-MSH 처리군α-MSH treatment group 100.00100.00 0.000.00 100.00100.00 0.000.00 100.00100.00 0.000.00 α-MSH +
제조예 13
α-MSH +
Manufacturing Example 13
2525 89.4889.48 0.490.49 85.8885.88 1.691.69 82.7982.79 2.022.02
5050 86.5386.53 0.290.29 82.7782.77 1.751.75 80.9080.90 0.690.69 100100 73.9973.99 1.401.40 67.0667.06 0.210.21 64.3064.30 0.420.42 α-MSH +
Arbutin
α-MSH +
Arbutin
100100 75.8575.85 1.541.54 78.4478.44 1.761.76 75.9275.92 2.692.69

상기 표 8 및 도 5에서 보듯이, 제조예 13 처리 시 α-MSH 인해 증가된 Tyrosinase, TRP-1 및 TRP-2 유전자 발현을 농도 의존적으로 현저하게 억제하는 것을 확인하였으며, 유전자 각각의 100 ㎍/㎖의 농도에서 양성 대조군으로 사용한 Arbutin 보다 멜라닌 생성 저해 효과가 더 뛰어난 것으로 확인되었다.As shown in Table 8 and FIG. 5, it was confirmed that the increased expression of Tyrosinase, TRP-1 and TRP-2 genes due to α-MSH during Preparation Example 13 treatment was significantly suppressed in a concentration-dependent manner, and 100 μg/of each gene It was confirmed that the inhibitory effect of melanin production was superior to Arbutin used as a positive control at a concentration of ml.

[실험예 6 : 멜라노좀 수송 관련 Rab27a, MyosinVa, Melanophilin mRNA 발현량 조사][Experimental Example 6: Investigation of the expression levels of Rab27a, MyosinVa, and Melanophilin mRNA related to melanosome transport]

본 실험에서는 상기 제조예 13 복합물의 멜라노좀 수송 관련 미백효과를 확인하고자 하였다.In this experiment, it was to confirm the whitening effect related to the transport of melanosomes of the composite of Preparation Example 13.

상업적으로 구입한 마우스의 멜라노마(B16-F1) 세포에 시료를 처리하여 실험을 실시하였다. 6 well plate에 10% 소혈청이 함유된 DMEM(Dulbecco’s modified Eagle’s medium) 배지와 멜라노마(B16-F1) 세포를 1.5×105세포/well 농도로 분주하고 24시간 동안 37℃, 5% CO2 조건에서 배양하였다.The experiment was carried out by treating the sample with melanoma (B16-F1) cells of commercially purchased mice. DMEM (Dulbecco's modified Eagle's medium) medium containing 10% bovine serum and melanoma (B16-F1) cells were dispensed at a concentration of 1.5×10 5 cells/well in a 6 well plate, and 37℃, 5% CO 2 for 24 hours. Incubated under conditions.

24시간 후 시료를 α-Melanocyte stimulate hormone(α-MSH)과 10% 소혈청이 포함된 새로운 DMEM 배지에 농도 별로 희석하여 18시간 동안 배양한다. 18시간 배양 후 배지 모두 제거한 세포를 PBS(phosphate buffer, saline) 2㎖로 세척하고 세포를 TRIzol(invitrogen, USA)로 모아 RNA를 분리하였다. 분리된 RNA를 Qubit fluoremeter with RNA BR Assay kit 를 이용하여 정량한 뒤 cDNA (complementary DNA)를 합성하여 Real-time PCR을 실시하였다. cDNA합성은 cDNA 합성 Kit (High Capacity RNA to-cDNA Kit, Applied Biosystems, USA)를 사용하였고 Kit의 방법에 따라 실험을 수행하였다. Real-Time PCR: 7500 Fast with Power SYBR Green PCR master mix (Applied Biosystems, USA)을 이용하여 유전자를 증폭한 후 증폭산물을 정량 분석하였다. PCR에 사용된 Rab27a, MyosinVa 및 Melanophilin과 GAPDH primer는 코스모진텍사 (Korea)에서 합성하여 사용하였으며 primer sequence는 아래 표 9에 나타내었다.After 24 hours, the sample is diluted by concentration in a new DMEM medium containing α-Melanocyte stimulate hormone (α-MSH) and 10% bovine serum and incubated for 18 hours. After 18 hours of culture, the cells from which all the medium was removed were washed with 2 ml of PBS (phosphate buffer, saline), and the cells were collected with TRIzol (invitrogen, USA) to isolate RNA. The isolated RNA was quantified using a Qubit fluoremeter with RNA BR Assay kit, and then cDNA (complementary DNA) was synthesized to perform real-time PCR. For cDNA synthesis, a cDNA synthesis Kit (High Capacity RNA to-cDNA Kit, Applied Biosystems, USA) was used, and an experiment was performed according to the method of the Kit. Real-Time PCR: After amplifying the gene using 7500 Fast with Power SYBR Green PCR master mix (Applied Biosystems, USA), the amplified product was quantitatively analyzed. Rab27a, MyosinVa, Melanophilin, and GAPDH primers used in PCR were synthesized and used by Cosmogenetec (Korea), and the primer sequence is shown in Table 9 below.

PrimerPrimer SenseSense AntisenseAntisense Rab27aRab27a 5'-ATGTCGGATGGAGATTACGA-3'5'-ATGTCGGATGGAGATTACGA-3' 5'-CCATAACTGCAGGTGGATTC-3'5'-CCATAACTGCAGGTGGATTC-3' MyosinVaMyosinVa 5'-AGTGCAGCAGCTAAGAGCAT-3'5'-AGTGCAGCAGCTAAGAGCAT-3' 5'-ATTCTTGCACGTTTGCTTTC-3'5'-ATTCTTGCACGTTTGCTTTC-3' MelanophilinMelanophilin 5'-AGCCCCTCAACAGCAAAAA-3'5'-AGCCCCTCAACAGCAAAAA-3' 5'-TTCCTCAAAGTCCACATCTCG-3'5'-TTCCTCAAAGTCCACATCTCG-3' GAPDHGAPDH 5'-GGCATCTTGGGCTACACTGAG-3'5'-GGCATCTTGGGCTACACTGAG-3' 5'-GGAAGAGTGGGAGTTGCTGTTG-3'5'-GGAAGAGTGGGAGTTGCTGTTG-3'

대조군(Control)은 용해 용매로 사용된 DMSO(dimethhyl sulfoxide)를 처리한 것을 사용하였으며, α-MSH 처리군은 용해 용매로 사용된 DMSO(dimethhyl sulfoxide)를 함께 처리한 것을 사용하였다. 실험결과는 아래 표 10 및 도 6에 나타내었다.The control group was treated with DMSO (dimethhyl sulfoxide) used as the dissolving solvent, and the α-MSH treatment group was treated with DMSO (dimethhyl sulfoxide) used as the dissolving solvent. The experimental results are shown in Table 10 and FIG. 6 below.

Sample NameSample Name Conc. (㎍/㎖)Conc. (㎍/mL) Rab27a
expression rate(%)
Rab27a
expression rate(%)
Stdev.Stdev. MyosinVa expression rate(%)MyosinVa expression rate(%) Stdev.Stdev. Melanophilin expression rate(%)Melanophilin expression rate (%) Stdev.Stdev.
ControlControl 52.1152.11 3.093.09 55.4055.40 2.372.37 79.2079.20 00.8300.83 α-MSH 처리군α-MSH treatment group 100.00100.00 0.000.00 100.00100.00 0.000.00 100.00100.00 0.000.00 α-MSH +
제조예 13
α-MSH +
Manufacturing Example 13
2525 92.1292.12 2.952.95 90.3790.37 0.520.52 85.2285.22 3.443.44
5050 86.6986.69 3.153.15 83.3383.33 2.272.27 83.5483.54 6.936.93 100100 78.7278.72 2.432.43 72.8772.87 2.352.35 71.6671.66 4.854.85

상기 표 10 및 도 6에서 보듯이, 제조예 13 처리 시 α-MSH 인해 증가된 Rab27a, MyosinVa 및 Melanophilin의 유전자 발현을 농도 의존적으로 억제하는 것을 확인하였다. As shown in Table 10 and FIG. 6, it was confirmed that the gene expression of Rab27a, MyosinVa, and Melanophilin increased due to α-MSH during Preparation Example 13 treatment was inhibited in a concentration-dependent manner.

[실시예 1 : 유연 화장수][Example 1: Flexible lotion]

성분ingredient 함량(중량%)Content (% by weight) 제조예 13Manufacturing Example 13 22 글리세린glycerin 5.05.0 1,3-부틸렌글리콜1,3-butylene glycol 3.03.0 REG 1500REG 1500 1.01.0 알란토인Allantoin 0.10.1 DL-판테놀DL-panthenol 0.30.3 EDTA-2NaEDTA-2Na 0.020.02 벤조페논-9Benzophenone-9 0.040.04 소듐 히아루로네이트Sodium hyaluronate 5.05.0 에탄올ethanol 10.010.0 옥틸도데세스-16Octyldodeces-16 0.20.2 폴리솔베이트 20Polysorbate 20 0.20.2 유니사이드-유 13Uniside-U 13 0.010.01 incense 미량a very small amount 증류수Distilled water 잔량Balance 합계Sum 100100

[실시예 2 : 영양 크림][Example 2: Nourishing Cream]

성분ingredient 함량(중량%)Content (% by weight) 제조예 13Manufacturing Example 13 22 친유형 모노스테아린산 글리세린Glycerin monostearate 1.51.5 세테아릴알콜Cetearyl alcohol 1.51.5 스테아린산Stearic acid 1.01.0 알란폴리솔베이트 60Allan Polysorbate 60 1.51.5 솔비타스테아레이트Sorbitastearate 0.60.6 이소스테아릴 이소스테레이트Isostearyl isosterate 5.05.0 스쿠알란Squalane 5.05.0 광물유Mineral oil 35.035.0 디메치콘Dimethicone 0.50.5 하이드록시에틸세룰로오스Hydroxyethyl cellulose 0.120.12 글리세린glycerin 6.06.0 트리에탄올아민Triethanolamine 0.70.7 향유니사이드-유13Hyang Uniside-U13 0.020.02 incense 미량a very small amount 증류수Distilled water 잔량Balance 합계Sum 100100

[실시예 3 : 마사지크림][Example 3: Massage cream]

성분ingredient 함량(중량%)Content (% by weight) 제조예 13Manufacturing Example 13 22 프로필렌글리콜Propylene glycol 66 글리세린glycerin 4.04.0 트리에탄올아민Triethanolamine 0.50.5 밀납Beeswax 2.02.0 토코페릴아세테이트Tocopheryl Acetate 0.10.1 폴리솔베이트 60Polysorbate 60 3.03.0 솔비탄세스퀴올레이트Sorbitansquioleate 2.52.5 세테아릴알코올Cetearyl alcohol 2.02.0 유동파라핀Floating paraffin 30.030.0 카르복시비닐폴리머Carboxyvinyl polymer 0.50.5 incense 미량a very small amount 증류수Distilled water 잔량Balance 합계Sum 100100

[실시예 4 : 팩][Example 4: Pack]

성분ingredient 함량(중량%)Content (% by weight) 제조예 13Manufacturing Example 13 22 글리세린glycerin 7.07.0 1,3-부틸렌 글리콜1,3-butylene glycol 3.03.0 스쿠알렌Squalene 3.03.0 디메치콘Dimethicone 3.03.0 소듐히아루로네이트Sodium hyaluronate 0.10.1 글리신Glycine 2.02.0 폴리아크릴아마이드Polyacrylamide 5.05.0 항산4화제Antioxidant 4 0.30.3 트리에탄올아민Triethanolamine 0.10.1 EDTAEDTA 0.10.1 방부제antiseptic 미량a very small amount 증류수Distilled water 잔량Balance 합계Sum 100100

Claims (8)

삼백초(Saururus chinensis) 잎, 포도씨(Grape seed), 마치현(Portulaca oleracea) 혼합물의 혼합 추출물 및 고두밥(rice)에 누룩을 접종하여 발효시킨 발효물을 포함하며,
상기 혼합물은,
삼백초 잎 1 중량부에 대하여, 포도씨 2 내지 3 중량부, 마치현 6 내지 7 중량부로 혼합되는 것을 특징으로 하는 피부 미백용 화장료 조성물.
Including a mixed extract of a mixture of Saururus chinensis leaves, Grape seed, and Portulaca oleracea , and fermented product fermented by inoculating yeast in rice,
The mixture,
A cosmetic composition for skin whitening, characterized in that it is mixed with 2 to 3 parts by weight of grape seeds and 6 to 7 parts by weight of machi-hyun based on 1 part by weight of the leaves of Sambaekcho.
삭제delete 제1항에 있어서,
상기 혼합 추출물과 발효물은,
건조 중량 기준으로, 혼합 추출물 70~95 중량부에 발효물 5~30 중량부로 혼합되는 것을 특징으로 하는 피부 미백용 화장료 조성물.
The method of claim 1,
The mixed extract and fermented product,
A cosmetic composition for skin whitening, characterized in that the fermented product is mixed in an amount of 5 to 30 parts by weight of the fermented product to 70 to 95 parts by weight of the mixed extract on a dry weight basis.
삼백초(Saururus chinensis) 잎 추출물, 포도씨(Grape seed) 추출물, 마치현(Portulaca oleracea) 추출물 및 고두밥(rice)에 누룩을 접종하여 발효시킨 발효물을 포함하며,
상기 삼백초 잎 추출물, 포도씨 추출물, 마치현 추출물은,
건조 중량 기준으로, 삼백초잎 추출물 1 중량부에 대하여, 포도씨 추출물 2 내지 3 중량부, 마치현 추출물 6 내지 7 중량부로 혼합되는 것을 특징으로 하는 피부 미백용 화장료 조성물.
Saururus chinensis leaf extract, grape seed extract, portulaca oleracea extract, and fermented product fermented by inoculating yeast on rice,
The Sambaekcho leaf extract, grape seed extract, and machi-hyeon extract,
Based on dry weight, with respect to 1 part by weight of Sambaekcho leaf extract, 2 to 3 parts by weight of grape seed extract, 6 to 7 parts by weight of machihyeon extract cosmetic composition for skin whitening, characterized in that mixed.
삭제delete 제4항에 있어서,
상기 삼백초 잎 추출물, 포도씨 추출물, 마치현 추출물 및 발효물은,
상기 삼백초 잎 추출물, 포도씨 추출물, 마치현 추출물을 합친 것 70~95 중량부에 발효물 5~30 중량부의 비율로 혼합되는 것을 특징으로 하는 피부 미백용 화장료 조성물.
The method of claim 4,
The Sambaekcho leaf extract, grape seed extract, portulaca oleracea extract and fermented product,
The cosmetic composition for skin whitening, characterized in that mixed in a ratio of 5 to 30 parts by weight of the fermented product to 70 to 95 parts by weight of the sum of the three baekcho leaf extract, grape seed extract, and machi-hyun extract.
제1항 또는 제4항에 있어서,
상기 추출물은,
추출용매로 에탄올 수용액을 사용하여 추출한 것임을 특징으로 하는 피부 미백용 화장료 조성물.
The method of claim 1 or 4,
The extract,
A cosmetic composition for skin whitening, characterized in that it is extracted using an aqueous ethanol solution as an extraction solvent.
제1항 또는 제4항에 있어서,
상기 발효물은,
발효 후, 여과를 거쳐 수득한 여과액인 것을 특징으로 하는 피부 미백용 화장료 조성물.
The method of claim 1 or 4,
The fermented product,
A cosmetic composition for skin whitening, characterized in that it is a filtrate obtained through filtration after fermentation.
KR1020190088973A 2019-07-23 2019-07-23 Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product KR102202554B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190088973A KR102202554B1 (en) 2019-07-23 2019-07-23 Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190088973A KR102202554B1 (en) 2019-07-23 2019-07-23 Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product

Publications (1)

Publication Number Publication Date
KR102202554B1 true KR102202554B1 (en) 2021-01-14

Family

ID=74141168

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190088973A KR102202554B1 (en) 2019-07-23 2019-07-23 Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product

Country Status (1)

Country Link
KR (1) KR102202554B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023282528A1 (en) * 2021-07-09 2023-01-12 코스맥스 주식회사 Skin whitening composition comprising extract from white leaf of saururus chinensis (lour.) baill

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990085941A (en) * 1998-05-23 1999-12-15 서경배 Whitening cosmetic composition containing grape extract
KR20020035925A (en) * 2000-11-07 2002-05-16 이세복 Cosmetics composition comprising extract powder with vitis vinifera l.fermented solution and having whitening and anti-wrinkle effect
KR20090034241A (en) * 2007-10-02 2009-04-07 동국대학교 산학협력단 A method for fermentation of natural plants and herbal medicines, a fermented product prepared therefrom and a paharmaceutical composition, a cosmetic compositon and a food composition comprising the product
KR20110015866A (en) * 2009-08-10 2011-02-17 (주)아모레퍼시픽 Composition containing concentrated makgeolli for antioxidation and whitening effect
KR20120036171A (en) * 2010-10-07 2012-04-17 임명진 Rice wine and herbal drug composition for skin care and its process, mask pack by using it
KR101238820B1 (en) * 2011-12-05 2013-03-04 박갑성 Soap composition using orient fermentation material and manufacturing method thereof
KR20150016648A (en) * 2013-08-05 2015-02-13 김홍기 The cosmetic composition using NURUK fermentation vinegar and a method of preparing it
KR101744579B1 (en) 2015-10-16 2017-06-08 에스케이바이오랜드 주식회사 Cosmetic composition comprising mixture extract of Nymphaea tetragona, Chamomilla recutita flower, Moringa, Portulace oleracea for skin-whitening
KR20180048408A (en) 2016-10-31 2018-05-10 주식회사 코씨드바이오팜 Whitening cosmetics containing the Saururus chinensis (Lour.) Baill. with improved whitening activity by Jeju Shindari fermentation method and producing method thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990085941A (en) * 1998-05-23 1999-12-15 서경배 Whitening cosmetic composition containing grape extract
KR20020035925A (en) * 2000-11-07 2002-05-16 이세복 Cosmetics composition comprising extract powder with vitis vinifera l.fermented solution and having whitening and anti-wrinkle effect
KR20090034241A (en) * 2007-10-02 2009-04-07 동국대학교 산학협력단 A method for fermentation of natural plants and herbal medicines, a fermented product prepared therefrom and a paharmaceutical composition, a cosmetic compositon and a food composition comprising the product
KR20110015866A (en) * 2009-08-10 2011-02-17 (주)아모레퍼시픽 Composition containing concentrated makgeolli for antioxidation and whitening effect
KR20120036171A (en) * 2010-10-07 2012-04-17 임명진 Rice wine and herbal drug composition for skin care and its process, mask pack by using it
KR101238820B1 (en) * 2011-12-05 2013-03-04 박갑성 Soap composition using orient fermentation material and manufacturing method thereof
KR20150016648A (en) * 2013-08-05 2015-02-13 김홍기 The cosmetic composition using NURUK fermentation vinegar and a method of preparing it
KR101744579B1 (en) 2015-10-16 2017-06-08 에스케이바이오랜드 주식회사 Cosmetic composition comprising mixture extract of Nymphaea tetragona, Chamomilla recutita flower, Moringa, Portulace oleracea for skin-whitening
KR20180048408A (en) 2016-10-31 2018-05-10 주식회사 코씨드바이오팜 Whitening cosmetics containing the Saururus chinensis (Lour.) Baill. with improved whitening activity by Jeju Shindari fermentation method and producing method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023282528A1 (en) * 2021-07-09 2023-01-12 코스맥스 주식회사 Skin whitening composition comprising extract from white leaf of saururus chinensis (lour.) baill

Similar Documents

Publication Publication Date Title
JP5020377B2 (en) Cosmetic composition for skin whitening containing Oyama lotus extract as an active ingredient
KR101730352B1 (en) Antioxidant composition for cosmetics composite, cosmetics composite containing the same, and Manufacturing method thereof
KR102020828B1 (en) Whitening cosmetics containing the Saururus chinensis (Lour.) Baill. with improved whitening activity by Jeju Shindari fermentation method and producing method thereof
KR20090056521A (en) Cosmetic composition for skin-aging protection and wrinkle improvement comprising the extract of nephelium lappaceum and litchi chinensis sonn as active ingredient
KR101525873B1 (en) Cosmetic composition containing Manufacturing method and Cultured wild Ginseng Roots, Hedysarum ussuriensis, Sophora flavescens and Adenophora triphylla by two-stage fermentation for improving skin
KR102111648B1 (en) Method for manufacturing prunus yedoensis leaves biorenovate extract and cosmetic composition for skin whitening containing the same
KR102202554B1 (en) Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product
KR101705847B1 (en) A composition for inhibiting degradation of collagen or promoting synthesis of collagen comprising barley extract or eriodictyol
KR20200064899A (en) Cosmetic Composition Containing Fraction of Extract Derived from Passiflora edulis for Skin-Whitening
KR102441009B1 (en) Methods for extracting compound from ginseng, ginseng extract comprising the compound and composition for enhancing skin barrier comprising the same
KR20180052157A (en) Cosmetic composition for whitening skin comprising extract of Sorbus aucuparia berry or fermented product of Sorbus aucuparia berry
KR20020015816A (en) Whitening cosmetics containing extracts from Ecklonia cava
KR102632084B1 (en) Cosmetic composition for anti-oxidation, skin whitening, and improving of skin wrinkle containing Sanguisorba officinalis extract
KR101050484B1 (en) Skin whitening composition containing lactone compound as an active ingredient
KR102168533B1 (en) Cosmetic composition for whitening or improving the facial color containing herb extracts
KR102325393B1 (en) Skin whitening cosmetic composition with bioconversion of Breea segeta extract
KR101781111B1 (en) Cosmetic composition containing extracts of magnolia officinalis, buplerum falcatum and/or schizonepeta tenuifolia
KR101970144B1 (en) Cosmetic composition for whitening with green tomato extracts, burdock root extracts and chickpea extracts
KR100744947B1 (en) Cosmetic Composition for Skin Whitening Comprising Extract of Cnidium officinale and Protease as Active Ingredients
KR100681700B1 (en) Cosmetic composition for skin whitening comprising senkyunolide a and gluconic acid as active ingredients
KR20140103633A (en) Cosmetic composition containing extract of Bambusoideae and Reynoutria japonica for anti-wrinkle or anti-aging
KR102124698B1 (en) Cosmetic composition for improving skin wrinkle or skin aging comprising mixture extract of Chrysanthemum morfiolium, Aloe vera, and Hedera Helix
KR20120036516A (en) Cosmetic compositions for skin whitening comprising broccoli seed extracts
KR20120118946A (en) Skin whitening complex containing trihydroxyisoflavone and glycyrrhiza uralensis extracts
KR101957435B1 (en) Method for preparing extract of fermented silkworm cocoon for improving antiwrinkle and a cosmetic composition containing the fermented extract of silkworm cocoon as an active ingredients

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant